CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-23 | Campoy Carlos Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2020-02-14 | Knifsend Robin Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +34,000 | 34,000 | ||
| 2020-02-14 | Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev. | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2020-02-14 | ROWLAND LLOYD A General Counsel | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2020-02-14 | Peterson Amy C. EVP, Chief Development Officer | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2020-02-14 | McCarthy Sean A. President and CEO | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2020-02-03 | HANNAH ALISON L. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2019-11-30 | McCarthy Sean A. President and CEO | Grant or award | +1,080 | $5.32 | $6K | 84,306 |
| 2019-10-15 | Peterson Amy C. EVP, Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2019-09-30 | McCarthy Sean A. President and CEO | Gift | −4,500 | 7,809 | ||
| 2019-06-19 | SCARLETT JOHN A Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2019-06-19 | Young Matthew P. Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2019-06-19 | GLUCK FREDERICK W Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2019-06-19 | Fuchs Charles S. Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2019-06-19 | Jones Elaine V Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2019-06-19 | Meyers James R Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2019-05-31 | ROWLAND LLOYD A General Counsel | Grant or award | +1,812 | $8.21 | $15K | 11,791 |
| 2019-05-31 | Knifsend Robin Principal Accounting Officer | Grant or award | +1,812 | $8.21 | $15K | 2,791 |
| 2019-05-31 | McCarthy Sean A. President and CEO | Grant or award | +695 | $8.21 | $6K | 83,226 |
| 2019-05-01 | Jones Elaine V Director | Grant or award · Stock Option (right to buy) | +28,000 | 28,000 |
Page 15 of 33 · 649 trades